Sunil Gupta, MD | Director
Sunil Gupta, MD, is a nationally recognized retinal surgeon, a successful entrepreneur, and a healthcare innovator in healthcare technologies, both biosciences and technology enabled services. His passion is to shoot the gap of unsolved problem areas in retinal care. He started his career as founder of Retina Specialty Institute (RSI) in Northwest Florida and Gulf Coast States, ensuring patients in these underserved markets received pioneering quality care with an emphasis on patient experience.
Dr. Gupta went on to found and serve as Chief Medical Officer of US Retina, one of the largest associations of retina physicians in the United States. The company was instrumental as the first GPO in the retina space as well as the first decision support ERP system for retina practices. Additionally, to address the leading cause of preventable blindness in working aged patients around the world, he founded and chairs Intelligent Retinal Imaging Systems (IRIS), an FDA-cleared, cloud-based telemedicine tool for the assessment of retinal eye disease, specifically diabetic retinopathy, in the primary care setting. The award-winning IRIS team is on a mission to end preventable blindness due to diabetic retinopathy and other conditions and are advancing the use of AI and physician reads in over 1.2 million patients here and around the world.
In addition to his clinical and entrepreneurial endeavors, Dr. Gupta has served as a principal investigator for numerous coveted retinal studies, contributing significantly to the advancement of retinal therapies approved over the last two decades. He serves on the advisory boards for most of the largest pharma companies in the retinal space.
Dr. Gupta is also a partner in the AI for Good initiative with Microsoft, leveraging artificial intelligence to improve healthcare outcomes and drive innovation in the field of retinal imaging and diagnostics.
